Oshin Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 21-06-2024
- Paid Up Capital ₹ 1.85 M
as on 21-06-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.75 Cr
as on 21-06-2024
- Satisfied Charges ₹ 11.73 Cr
as on 21-06-2024
- Revenue -65.44%
(FY 2022)
- Profit -4229.62%
(FY 2022)
- Ebitda 393.31%
(FY 2022)
- Net Worth -26.00%
(FY 2022)
- Total Assets -7.29%
(FY 2022)
About Oshin Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.85 M.
The company currently has active open charges totaling ₹22.75 Cr. The company has closed loans amounting to ₹11.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ravinder Singh and Rajanbir Singh serve as directors at the Company.
- CIN/LLPIN
U24239DL2003PTC122886
- Company No.
122886
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Oshin Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravinder Singh  | Director | 01-Jan-2011 | Current |
| Rajanbir Singh | Director | 12-Jun-2013 | Current |
Financial Performance of Oshin Laboratories.
Oshin Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 65.44% decrease. The company also saw a substantial fall in profitability, with a 4229.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oshin Laboratories?
In 2021, Oshin Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 17 Apr 2010 | ₹3.50 M | Open |
Oriental Bank Of Commerce Creation Date: 08 Jun 2009 | ₹5.25 Cr | Open |
Oriental Bank Of Commerce Creation Date: 08 Jun 2009 | ₹5.25 Cr | Open |
How Many Employees Work at Oshin Laboratories?
Unlock and access historical data on people associated with Oshin Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oshin Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oshin Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
